IVD labeled staining reagents for manual and automated staining platforms from DBS

NewsGuard 100/100 Score

Diagnostic Biosystems (DBS), a specialty immunohistochemistry (IHC) reagent company, announces the availability of products for clinical use in the US.

Founded in 1994 as a life science supplier of novel, high quality IHC products in over 45 countries, DBS introduces a complete selection of IVD labeled staining reagents suitable for manual and automated staining platforms. DBS offers IVD labeled concentrated and pre-diluted ready-to-use primary antibodies and immunostaining detection systems for rabbit and mouse antibodies: advanced biotin-free polymer systems as well as traditional streptavidin-biotin systems labeled with horseradish peroxidase or alkaline phosphatase.

Unique to the Diagnostic Biosystems offering are antibody cocktails and proprietary chromogens for multicolor staining, focused on improving sensitivity and defining morphology on one tissue section for potentially cancerous cells. Novel antibodies and multi-stain products include:

  • PIN4
  • DOG-1
  • Napsin A
  • OCT4
  • PermaRed/AP-Auto
  • PermaBlue/AP
  • PermaGreen/AP
  • Stable DAB/Plus

“Diagnostic Biosystems is focused on developing clinically relevant, IVD labeled products for pathologists in the US. We are dedicated to providing the highest quality reagents for clinical labs. We understand high quality staining is the key to better diagnosis by Pathologists. We are committed to improving immunostaining one slide at a time," said Dr. Bipin Gupta, PhD, President & CEO.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
First study to report isolation of M. saskatchewanense from medical devices